4.7 Review

Unique catalytic activities and scaffolding of p21 activated kinase-1 in cardiovascular signaling

Journal

FRONTIERS IN PHARMACOLOGY
Volume 4, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2013.00116

Keywords

scaffolding; auto-phosphorylation; cytoskeletal reorganization; cardiovascular diseases; FTY720

Funding

  1. National Institute of Health (USA)
  2. UIC CCTS
  3. Medical Research Council (UK)
  4. British Heart Foundation [PG/11/59/29006] Funding Source: researchfish

Ask authors/readers for more resources

P21 activated kinase-1 (Pak1) has diverse functions in mammalian cells. Although a large number of phosphoproteins have been designated as Pak1 substrates from in vitro studies, emerging evidence has indicated that Pak1 may function as a signaling molecule through a unique molecular mechanism scaffolding. By scaffolding, Pak1 delivers signals through an auto-phosphorylation-induced conformational change without transfer of a phosphate group to its immediate downstream effector(s). Here we review evidence for this regulatory mechanism based on structural and functional studies of Pak1 in different cell types and research models as well as in vitro biochemical assays. We also discuss the implications of Pak1 scaffolding in disease-related signaling processes and the potential in cardiovascular drug development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available